140 related articles for article (PubMed ID: 35950060)
1. Screening of BRCA1 (c.5177_5180delGAAA rs80357867 and c.4986+6T>C rs80358086) and the BRCA2 (c.6445_6446delAT rs80359592) Genes for Breast Cancer Prevention in Burkina Faso.
Kiendrebeogo IT; Zoure AA; Zongo FI; Ouedraogo SY; Sawadogo AY; Amegnona J; Sombie HK; Bazie JTVE; Sorgho PA; Yonli AT; Ouedraogo MNL; Obiri-Yeboah D; Zongo N; Bambara HA; Simpore J
Ethiop J Health Sci; 2022 Jul; 32(4):699-708. PubMed ID: 35950060
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso.
Biancolella M; Ouédraogo NLM; Zongo N; Zohoncon TM; Testa B; Rizzacasa B; Latini A; Conte C; Compaore TR; Ouedraogo CMR; Traore SS; Simpore J; Novelli G
Hum Genomics; 2021 Oct; 15(1):65. PubMed ID: 34717758
[TBL] [Abstract][Full Text] [Related]
3. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
[TBL] [Abstract][Full Text] [Related]
4. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
5. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
[TBL] [Abstract][Full Text] [Related]
6. Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.
Nilsson MP; Winter C; Kristoffersson U; Rehn M; Larsson C; Saal LH; Loman N
Fam Cancer; 2017 Apr; 16(2):187-193. PubMed ID: 28120249
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
8. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
9. The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients.
Saleem M; Ghazali MB; Wahab MAMA; Yusoff NM; Mahsin H; Seng CE; Khalid IA; Rahman MNG; Yahaya BH
Adv Exp Med Biol; 2020; 1292():1-12. PubMed ID: 29687286
[TBL] [Abstract][Full Text] [Related]
10. Identification of BRCA1/2 p.Ser1613Gly, p.Pro871Leu, p.Lys1183Arg, p.Glu1038Gly, p.Ser1140Gly, p.Ala2466Val, p.His2440Arg variants in women under 45 years old with breast nodules suspected of having breast cancer in Burkina Faso.
Sagna T; Bonora E; Ouedraogo MNL; Fusco D; Zoure AA; Bisseye C; Djigma F; Kafando JG; Zongo N; Douamba Z; Obiri-Yeboah D; Turchetti D; Pietra V; Lompo OM; Ouedraogo C; Seri M; Simpore J
Biomol Concepts; 2019 Jun; 10(1):120-127. PubMed ID: 31203256
[TBL] [Abstract][Full Text] [Related]
11. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
Bernstein JL; Thomas DC; Shore RE; Robson M; Boice JD; Stovall M; Andersson M; Bernstein L; Malone KE; Reiner AS; Lynch CF; Capanu M; Smith SA; Tellhed L; Teraoka SN; Begg CB; Olsen JH; Mellemkjaer L; Liang X; Diep AT; Borg A; Concannon P; Haile RW;
Eur J Cancer; 2013 Sep; 49(14):2979-85. PubMed ID: 23706288
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
Abbas S; Siddique A; Shahid N; Khan RT; Fatima W
Breast Cancer; 2019 May; 26(3):365-372. PubMed ID: 30430339
[TBL] [Abstract][Full Text] [Related]
14. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.
; ;
Breast Cancer Res Treat; 2008 May; 109(1):67-75. PubMed ID: 17972172
[TBL] [Abstract][Full Text] [Related]
15. BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.
Berzina D; Nakazawa-Miklasevica M; Zestkova J; Aksenoka K; Irmejs A; Gardovskis A; Kalniete D; Gardovskis J; Miklasevics E
BMC Med Genet; 2013 Jun; 14():61. PubMed ID: 23767878
[TBL] [Abstract][Full Text] [Related]
16. Five Italian Families with Two Mutations in
Vietri MT; Caliendo G; D'Elia G; Resse M; Casamassimi A; Minucci PB; Dello Ioio C; Cioffi M; Molinari AM
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33287145
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing Identifies
Peker Eyüboğlu İ; Yenmiş G; Bingöl EN; Yüksel Ş; Tokat F; Özbek P; Güllü Amuran G; Yakıcıer C; Akkiprik M
OMICS; 2020 Jan; 24(1):5-15. PubMed ID: 31851867
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Karami F; Mehdipour P
Biomed Res Int; 2013; 2013():928562. PubMed ID: 24312913
[TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region.
Elalaoui SC; Laarabi FZ; Afif L; Lyahyai J; Ratbi I; Jaouad IC; Doubaj Y; Sahli M; Ouhenach M; Sefiani A
Breast Cancer Res Treat; 2022 Jul; 194(1):187-198. PubMed ID: 35578052
[TBL] [Abstract][Full Text] [Related]
20. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.
Dodova RI; Mitkova AV; Dacheva DR; Hadjo LB; Vlahova AI; -Hadjieva MST; Valev SS; Caulevska MM; Popova SD; Popov IE; Dikov TI; Sedloev TA; Ionkov AS; Timcheva KV; Christova SL; Kremensky IM; Mitev VI; Kaneva RP
BMC Cancer; 2015 Jul; 15():523. PubMed ID: 26183948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
